Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

Chamie-Quintero et al., Preprint, doi:10.2139/ssrn.3765018
Jan 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now with p < 0.00000000001 from 104 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19ivm.org
Analysis of ivermectin usage within states in Peru showing sharp reductions in COVID-19 deaths corresponding to the usage of ivermectin treatment.
Chamie-Quintero et al., 21 Jan 2021, preprint, 3 authors.
This PaperIvermectinAll
Sharp reductions in COVID-19 case fatalities and excess deaths in Peru in close time conjunction, state-by-state, with ivermectin treatments
Juan J Chamie-Quintero, Jennifer A Hibberd, PhD David E Scheim
A) Excess all-cause deaths; B) COVID-19 case fatalities; and C) case incidence data for eight states in Peru that deployed mass ivermectin (IVM) treatments early in their pandemic spread (blue) and for Lima, which deployed IVM treatment four months later (red). D) Excess deaths for nine states having mass IVM distributions in a short period through national operation "MOT" (see results section for sources). • MOT start date; ▲peak deaths; ■ day of peak deaths + 30 days. Junin (yellow) distributed IVM to health centers beginning on July 22, 13 days before MOT start. Population-weighted mean deaths for these nine states dropped sharply, -74% at +30 days, beginning (except for Junin) 1 to 11 days after MOT start. All y values are 7-day moving averages, ages ≥ 60.
Supplementary information is retrievable at https://drive.google.com/file/d/1bjm62m0NwL_1cGPSYyQjjgu3Xas0rkSR/view?usp=sharing
References
Alam, Murshed, Bhiuyan, A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline, Journal of Bangladesh College of Physicians and Surgeons
Arseculeratne, Arseculeratne, A re-appraisal of the conventional history of antibiosis and Penicillin, Mycoses
Award Ceremony ; Dr, Omura, None
Badhan, Zakaria, Olafuyi, The Repurposing of Ivermectin for Malaria: A Prospective Pharmacokinetics-Based Virtual Clinical Trials Assessment of Dosing Regimen Options, Journal of Pharmaceutical Sciences
Badr, Du, Marshall, Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study, The Lancet Infectious Diseases
Baker, Richards, Guy, The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device, ACS Central Science
Bennett, Chung, Alexander Fleming and the discovery of penicillin, Advances in Applied Microbiology
Cabezas, Fiestas, García-Mendoza, Dengue en el Perú: a un cuarto de siglo de su reemergencia, Revista Peruana de Medicina Experimental y Salud Publica
Caly, Druce, Catton, The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Res
Carvallo, Hirsch, Farinella, Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID-19, medRxiv, doi:10.1101/2020.09.10.20191619
Cenares, Ministerio de Salud de Peru
Chaccour, Casellas, Blanco-Di Matteo, The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial, EClinicalMedicine
Chen, Liu, Liu, A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19), J Zhejiang Univ (Med Sci)
Chowdhury, Shahbaz, Karim, A comparative study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin therapy on COVID19 patients
Condezo, Facebook
Corsig, Soloway, Stanaro, Glaxo Holdings PLC: Zantac
Crump, Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations, J Antibiot
Cruz, Testimonio del Sub Oficial Darvin Condezo
Dai, Gao, Viral targets for vaccines against COVID-19, Nature Reviews Immunology
Dayer, Coronavirus (2019-nCoV) Deactivation via Spike Glycoprotein Shielding by Old Drugs, Bioinformatic Study, doi:10.20944/preprints202005.0020.v1
Dr, Fernando Massé sobre la ivermectina
Dr, Massé indicó en qué momento es más efectiva consumir ivermectina
Dr, Omura, lecture at the Showa Pharmaceutical University
Elgzazzar, Hany, Youssef, Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic, Research Square, doi:10.21203/rs.3.rs-100956/v1
Epdsesa, Covid-19: a más de 22,000 personas atendió Operación Tayta-Yo Me Apunto en Cajamarca
Espitia-Hernandez, Munguia, Diaz-Chiguer, Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on COVID-19 infected patients: A proof of concept study, Biomedical Research
Florey, Adelaide, Florey, General and local administration of penicillin, The Lancet
Fonseca, Exclusive, Study suggests dengue may provide some immunity against COVID-19
George, Borody, Andrews, Cure of duodenal ulcer after eradication of Helicobacter pylori, Med J Aust
Gorial, Mashhadani, Sayaly, Effectiveness of Ivermectin as add-on Therapy in COVID-19
Greaney, Loes, Crawford, Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies, bioRxiv, doi:10.1101/2020.12.31.425021
Greaney, Starr, Gilchuk, Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition, Cell Host & Microbe
Guzzo, Furtek, Porras, Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects, J Clin Pharmacol
Hashim, Maulood, Rasheed, Controlled randomized clinical trial on using Ivermectin with Doxycycline for treating COVID-19 patients in Baghdad, Iraq, doi:10.1101/2020.10.26.20219345
Hussien, Abdelaziz, Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease, Network Modeling Analysis in Health Informatics and Bioinformatics
Ietsi, None, Instituto de Evaluación de Tecnologías en Salud e Investigación
Juscamayta-López, Tarazona, Valdivia, Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru, bioRxiv, doi:10.1101/2020.09.14.296814
Kalhor, Sadeghi, Abolhasani, Repurposing of the approved small molecule drugs in order to inhibit SARS-CoV-2 S protein and human ACE2 interaction through virtual screening approaches, Journal of Biomolecular Structure and Dynamics
Keefer, Blake, Marshall, Penicillin in the treatment of infections; 500 cases, Journal of the American Medical Association
Kingston, Antibiotics, invention and innovation, Research Policy
Krolewiecki, Lifschitz, Moragas, Antiviral effect of high-dose ivermectin in adults with COVID-19: a pilot randomised, controlled, open label, multicentre trial
Lam, Murphy, Kuri-Cervantes, Erythrocytes Reveal Complement Activation in Patients with COVID-19, medRxiv, doi:10.1101/2020.05.20.20104398
Lawrence, Sodahlon, Ogoussan, Growth, Challenges, and Solutions over 25 Years of Mectizan and the Impact on Onchocerciasis Control, PLoS Negl Trop Dis
Lehrer, Rheinstein, Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2, Vivo
Ligon, Penicillin: its discovery and early development, Seminars in Pediatric Infectious Diseases
Llantoy, Mediante empadronamiento ejecutado por 60 brigadistas de la mph y "amachay
Luna, Repartirán 10 mil kits con Ivermectina para combatir Covid-19 en Tuxtla
Lyons, Penicillin therapy of surgical infections in the US Army: A report, Journal of the American Medical Association
Marshall, Goodwin, Warren, Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori, Lancet
Marshall, Helicobacter Connections
Marshall, Nobel Prize biography
Martín De Porres, incautan 20,000 frascos de ivermectina y detienen a 12 personas
Maurya, A Combination of Ivermectin and Doxycycline Possibly Blocks the Viral Entry and Modulate the Innate Immune Response in COVID-19 Patients, ChemRxiv, doi:10.26434/chemrxiv.12630539.v1
Minsa, Casos confirmados por coronavirus Covid-19 ascienden a 818 297 en el Perú
Modrof, Kerschbaum, Farcet, SARS-CoV-2 and the safety margins of cell-based biological medicinal products, Biologicals
Momekov, Momekova, Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens, Biotechnology & Biotechnological Equipment
Moquegua, llegan otros 45 médicos desde Lima para reforzar lucha contra el coronavirus
Muik, Wallisch, Sänger, Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera, bioRxiv, doi:10.1101/2021.01.18.426984
Munnangi, Sonnenberg, Time trends of physician visits and treatment patterns of peptic ulcer disease in the United States, Arch Intern Med
Nallusamy, Mannu, Ravikumar, Shortlisting Phytochemicals Exhibiting Inhibitory Activity against Major Proteins of SARS-CoV-2 through Virtual Screening, Research Square, doi:10.21203/rs.3.rs-31834/v1
Niaee, Gheibi, Namdar, Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients; A randomized multi-center clinical trial, Research Square, doi:10.21203/rs.3.rs-109670/v1
Nicolas, Maia, Bassat, Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis, The Lancet Global Health
O'donohue, Lilienfeld, Professional issues and evidence-based practice: The quality problem in behavioral health care, doi:10.1002/9781118156391
Offord, Surgisphere Sows Confusion About Another Unproven COVID-19 Drug, The Scientist
Oh, Lee, Long, How well does societal mobility restriction help control the COVID-19 pandemic? Evidence from real-time evaluation, medRxiv, doi:10.1101/2020.10.29.20222414
Piura, Detienen a dos personas con más de 200 dosis de ivermectina de contrabando; coronavirus; COVID-19
Polack, Thomas, Kitchin, Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (study protocol), N Engl J Med
Polack, Thomas, Kitchin, Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, N Engl J Med
Prof, None
Puno, Desde mañana implementarán la operación Tayta liderado por el Ejército peruano
Rajter, Sherman, Fatteh, Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19, ICON study, doi:10.1016/j.chest.2020.10.009
Richards, Production of Penicillin in the United States (1941-1946), Nature
Rojas, Amaya, Grupo de médicos recomiendan descontinuar uso no supervisado de hidroxicloroquina e ivermectina
Scheim, From cold to killer: How SARS-CoV-2 evolved without hemagglutinin esterase to agglutinate, then clot blood cells in pulmonary and systemic microvasculature
Scheim, Ivermectin for COVID-19 treatment: clinical response at quasi-threshold doses via hypothesized alleviation of CD147-mediated vascular occlusion
Schmith, Zhou, Lohmer, The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19, Clin Pharmacol Ther
Shouman, Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close Contacts with Patients of COVID
Stokes, Turner, Anselmi, The relative effects of non-pharmaceutical interventions on early Covid-19 mortality: natural experiment in 130 countries, medRxiv, doi:10.1101/2020.10.05.20206888
Suravajhala, Parashar, Malik, Comparative Docking Studies on Curcumin with COVID-19 Proteins, doi:10.20944/preprints202005.0439.v2
Unwin, Mishra, Bradley, State-level tracking of COVID-19 in the United States, Nature Communications
Weisblum, Schmidt, Zhang, Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants, eLife
Welsh, Inequality and corruption: Why Peru is losing its COVID-19 battle, Devex
Wendler, Ochoa, Millum, COVID-19 vaccine trial ethics once we have efficacious vaccines, Science
Wibmer, Ayres, Hermanus, SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma, bioRxiv, doi:10.1101/2021.01.18.427166
Wu, Werner, Moliva, mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants, bioRxiv
Yumbato, Coronavirus en Perú: Experiencia médica funcionó en pacientes peruanos
Yumbato, Coronavirus en Perú: conoce cómo funciona la Operación Tayta
{ 'indexed': {'date-parts': [[2023, 11, 1]], 'date-time': '2023-11-01T17:00:52Z', 'timestamp': 1698858052737}, 'reference-count': 119, 'publisher': 'Elsevier BV', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.2139/ssrn.3765018', 'type': 'journal-article', 'created': {'date-parts': [[2021, 1, 22]], 'date-time': '2021-01-22T05:48:44Z', 'timestamp': 1611294524000}, 'source': 'Crossref', 'is-referenced-by-count': 6, 'title': 'Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time ' 'Conjunction, State-By-State, with Ivermectin Treatments', 'prefix': '10.2139', 'author': [ {'given': 'Juan', 'family': 'Chamie-Quintero', 'sequence': 'first', 'affiliation': []}, {'given': 'Jennifer', 'family': 'Hibberd', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Scheim', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': 'ref1', 'journal-title': 'Primer caso de coronavirus en Per�: Los detalles del contagio del ' 'piloto | PERU'}, { 'key': 'ref2', 'article-title': 'Ministerio De Salud', 'year': '2020', 'journal-title': 'Resolucion Ministerial #270-2020'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'first-page': '92', 'DOI': '10.1016/s2214-109x(19)30453-x', 'volume': '8', 'author': 'P Nicolas', 'year': '2020', 'journal-title': 'Safety of oral ivermectin during pregnancy: a systematic review and ' 'meta-analysis. The Lancet Global Health'}, { 'issue': '5', 'key': 'ref4', 'doi-asserted-by': 'publisher', 'first-page': '495', 'DOI': '10.1038/ja.2017.11', 'article-title': "Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise " 'and exceed expectations', 'volume': '70', 'author': 'A Crump', 'year': '2017', 'journal-title': 'J Antibiot (Tokyo)'}, { 'issue': '5', 'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pntd.0003507', 'article-title': 'Growth, Challenges, and Solutions over 25 Years of Mectizan and the ' 'Impact on Onchocerciasis Control', 'volume': '9', 'author': 'J Lawrence', 'year': '2015', 'journal-title': 'PLoS Negl Trop Dis'}, { 'issue': '8', 'key': 'ref6', 'doi-asserted-by': 'publisher', 'first-page': '2236', 'DOI': '10.1016/j.xphs.2018.03.026', 'article-title': 'The Repurposing of Ivermectin for Malaria: A Prospective ' 'PharmacokineticsBased Virtual Clinical Trials Assessment of Dosing ' 'Regimen Options', 'volume': '107', 'author': 'R Badhan', 'year': '2018', 'journal-title': 'Journal of Pharmaceutical Sciences'}, { 'key': 'ref7', 'year': '1993', 'journal-title': 'Constituci�n Pol�tica Del Per�, 29 de diciembre de'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'L Caly', 'year': '2020', 'journal-title': 'Antiviral Res'}, { 'key': 'ref9', 'author': 'C Offord', 'year': '2020', 'journal-title': 'Surgisphere Sows Confusion About Another Unproven COVID-19 Drug. The ' 'Scientist'}, { 'issue': '1', 'key': 'ref10', 'doi-asserted-by': 'publisher', 'first-page': '469', 'DOI': '10.1080/13102818.2020.1775118', 'article-title': 'Ivermectin as a potential COVID-19 treatment from the pharmacokinetic ' 'point of view: antiviral levels are not likely attainable with known ' 'dosing regimens', 'volume': '34', 'author': 'G Momekov', 'year': '2020', 'journal-title': 'Biotechnology & Biotechnological Equipment'}, { 'issue': '4', 'key': 'ref11', 'doi-asserted-by': 'publisher', 'first-page': '762', 'DOI': '10.1002/cpt.1889', 'article-title': 'The Approved Dose of Ivermectin Alone is not the Ideal Dose for the ' 'Treatment of COVID-19', 'volume': '108', 'author': 'V D Schmith', 'year': '2020', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': 'ref12', 'doi-asserted-by': 'publisher', 'author': 'C Chaccour', 'journal-title': 'The effect of early treatment with ivermectin on viral load, symptoms ' 'and humoral response in patients with non-severe COVID-19: A pilot, ' 'double-blind, placebo-controlled', 'DOI': '10.1016/j.eclinm.2020.100720'}, { 'key': 'ref13', 'year': '2020', 'journal-title': 'Watanabe Award Ceremony, presentation by Dr. Satoshi Omura, video ' 'segment beginning at 50:00'}, { 'key': 'ref14', 'article-title': 'Scheim and others, cc. Dr. Satoshi Omura, conveying this video greeting ' 'from Dr. Omura for a videoconference on ivermection for COVID-19 ' 'sponsored by Medincell', 'volume': '18', 'author': 'Satoshi Dr', 'year': '2020', 'journal-title': 'video segment beginning at 1:07. October'}, { 'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.chest.2020.10.009', 'article-title': 'Use of Ivermectin is Associated with Lower Mortality in Hospitalized ' 'Patients with COVID-19 (ICON study)', 'author': 'J C Rajter', 'year': '2020', 'journal-title': 'CHEST'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.10.26.20219345', 'article-title': 'Controlled randomized clinical trial on using Ivermectin with ' 'Doxycycline for treating COVID-19 patients in Baghdad', 'author': 'H A Hashim', 'year': '2020', 'journal-title': 'Iraq. medRxiv'}, { 'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.21203/rs.3.rs-100956/v1', 'article-title': 'Efficacy and Safety of Ivermectin for Treatment and prophylaxis of ' 'COVID-19 Pandemic', 'author': 'A Elgzazzar', 'year': '2020', 'journal-title': 'Research Square'}, { 'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.21203/rs.3.rs-109670/v1', 'article-title': 'Ivermectin as an adjunct treatment for hospitalized adult COVID-19 ' 'patients; A randomized multi-center clinical trial', 'author': 'M S Niaee', 'year': '2020', 'journal-title': 'Research Square'}, { 'key': 'ref19', 'author': 'R Mahmud', 'year': '2020', 'journal-title': 'Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of ' 'Confirmed Covid-19 Infection'}, { 'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.09.10.20191619', 'article-title': 'Safety and Efficacy of the combined use of ivermectin, dexamethasone, ' 'enoxaparin and aspirin against COVID-19', 'author': 'H E Carvallo', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': 'ref21', 'doi-asserted-by': 'publisher', 'author': 'F I Gorial', 'journal-title': 'Effectiveness of Ivermectin as add-on Therapy in COVID-19', 'DOI': '10.1101/2020.07.07.20145979'}, { 'key': 'ref22', 'doi-asserted-by': 'publisher', 'year': '2020', 'journal-title': 'Management (Pilot Trial). medRxiv', 'DOI': '10.1101/2020.07.07.20145979'}, { 'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.3329/jbcps.v38i0.47512', 'article-title': 'A Case Series of 100 COVID-19 Positive Patients Treated with ' 'Combination of Ivermectin and Doxycycline', 'volume': '38', 'author': 'M Alam', 'year': '2020', 'journal-title': 'Journal of Bangladesh College of Physicians and Surgeons'}, { 'key': 'ref24', 'author': 'A T Chowdhury', 'year': '2020', 'journal-title': 'A comparative study on Ivermectin-Doxycycline and ' 'Hydroxychloroquine-Azithromycin therapy on COVID19 patients'}, { 'issue': '5', 'key': 'ref25', 'first-page': '129', 'article-title': 'Effects of Ivermectin-azithromycin-cholecalciferol combined therapy on ' 'COVID-19 infected patients: A proof of concept study', 'volume': '31', 'author': 'G Espitia-Hernandez', 'year': '2020', 'journal-title': 'Biomedical Research'}, { 'key': 'ref26', 'author': 'W Shouman', 'journal-title': 'Use of Ivermectin as a Prophylactic Option in Asymptomatic Family Close ' 'Contacts with Patients of COVID-19 (NCT number: 04422561)'}, { 'key': 'ref27', 'doi-asserted-by': 'publisher', 'DOI': '10.20944/preprints202005.0020.v1', 'article-title': '2019-nCoV) Deactivation via Spike Glycoprotein Shielding by Old Drugs', 'author': 'M Dayer', 'year': '2020', 'journal-title': 'Bioinformatic Study. Preprints.org'}, { 'key': 'ref28', 'doi-asserted-by': 'publisher', 'DOI': '10.26434/chemrxiv.12630539.v1', 'article-title': 'A Combination of Ivermectin and Doxycycline Possibly Blocks the Viral ' 'Entry and Modulate the Innate Immune Response in COVID-19 Patients', 'author': 'D Maurya', 'year': '2020', 'journal-title': 'ChemRxiv'}, { 'issue': '1', 'key': 'ref29', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s13721-020-00263-6', 'article-title': 'Molecular docking suggests repurposing of brincidofovir as a potential ' 'drug targeting SARS-CoV-2 ACE2 receptor and main protease', 'volume': '9', 'author': 'M A Hussien', 'year': '2020', 'journal-title': 'Network Modeling Analysis in Health Informatics and Bioinformatics'}, { 'key': 'ref30', 'doi-asserted-by': 'publisher', 'DOI': '10.20944/preprints202005.0439.v2', 'article-title': 'Comparative Docking Studies on Curcumin with COVID-19 Proteins', 'author': 'R Suravajhala', 'year': '2020', 'journal-title': 'Preprints.org'}, { 'key': 'ref31', 'doi-asserted-by': 'publisher', 'DOI': '10.21203/rs.3.rs-31834/v1', 'article-title': 'Shortlisting Phytochemicals Exhibiting Inhibitory Activity against ' 'Major Proteins of SARS-CoV-2 through Virtual Screening', 'author': 'S Nallusamy', 'year': '2020', 'journal-title': 'Research Square'}, { 'issue': '5', 'key': 'ref32', 'doi-asserted-by': 'publisher', 'first-page': '3023', 'DOI': '10.21873/invivo.12134', 'article-title': 'Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain ' 'Attached to ACE2', 'volume': '34', 'author': 'S Lehrer', 'year': '2020', 'journal-title': 'In Vivo'}, { 'key': 'ref33', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/07391102.2020.1824816:1-16', 'article-title': 'Repurposing of the approved small molecule drugs in order to inhibit ' 'SARS-CoV-2 S protein and human ACE2 interaction through virtual ' 'screening approaches', 'author': 'H Kalhor', 'year': '2020', 'journal-title': 'Journal of Biomolecular Structure and Dynamics'}, { 'key': 'ref34', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41577-020-00480-0', 'article-title': 'Viral targets for vaccines against COVID-19', 'author': 'L Dai', 'year': '2020', 'journal-title': 'Nature Reviews Immunology'}, { 'key': 'ref35', 'doi-asserted-by': 'publisher', 'DOI': '10.2139/ssrn.3706347', 'volume': '12', 'author': 'D Scheim', 'year': '2020', 'journal-title': 'From cold to killer: How SARS-CoV-2 evolved without hemagglutinin ' 'esterase to agglutinate, then clot blood cells in pulmonary and ' 'systemic microvasculature'}, { 'key': 'ref36', 'doi-asserted-by': 'publisher', 'first-page': '122', 'DOI': '10.1016/j.biologicals.2020.08.010', 'article-title': 'SARS-CoV-2 and the safety margins of cell-based biological medicinal ' 'products', 'volume': '68', 'author': 'J Modrof', 'year': '2020', 'journal-title': 'Biologicals'}, { 'key': 'ref37', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.05.20.20104398', 'article-title': 'Erythrocytes Reveal Complement Activation in Patients with COVID-19', 'author': 'L M Lam', 'year': '2020', 'journal-title': 'medRxiv'}, { 'issue': '11', 'key': 'ref38', 'doi-asserted-by': 'publisher', 'first-page': '2046', 'DOI': '10.1021/acscentsci.0c00855', 'article-title': 'The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid ' 'Detection in a Lateral Flow Point of Care Diagnostic Device', 'volume': '6', 'author': 'A N Baker', 'year': '2020', 'journal-title': 'ACS Central Science'}, { 'key': 'ref39', 'journal-title': 'Mazzetti informa que se retirar� hidroxicloroquina de gu�a de ' 'tratamiento covid-19. Andina, Agencia Peruana de Noticias'}, { 'key': 'ref40', 'author': 'Carillo Rojas', 'journal-title': 'Grupo de m�dicos recomiendan descontinuar uso no supervisado de ' 'hidroxicloroquina e ivermectina'}, { 'key': 'ref41', 'volume': '2020', 'journal-title': 'Era insostenible: Minsa actualiza su gu�a de tratamiento Covid-19 y ' 'retira a hidroxicloroquina'}, { 'key': 'ref42', 'journal-title': 'Gobierno inicia Operaci�n TAYTA para proteger a la poblaci�n vulnerable ' 'ante COVID-19 en zonas de riesgo'}, { 'key': 'ref43', 'journal-title': 'Alcalde de Lima debe convocar a empresariado y gobierno para aplicar ' 'cercos familiares masivos; Lampadia'}, { 'key': 'ref44', 'author': 'A Yumbato', 'journal-title': 'Ivermectina: Testimonios de personas que utilizaron este medicamento en ' 'tiempo de coronavirus'}, { 'key': 'ref45', 'author': 'A Yumbato', 'journal-title': 'Coronavirus en Per�: Experiencia m�dica funcion� en pacientes peruanos'}, { 'key': 'ref46', 'journal-title': 'Se recuperaron: Cinco congresistas de Podemos Per� ya est�n ' 'pr�cticamente libres del COVID-19'}, { 'issue': '2020', 'key': 'ref47', 'article-title': 'Ivermectina: Lo que debes saber sobre este medicamento en tiempo de ' 'coronavirus', 'volume': '11', 'author': '�mpetu', 'journal-title': 'Pucallpa'}, { 'key': 'ref48', 'article-title': 'Polic�a asegura que f�rmaco lo sac� de cuadro cr�tico de COVID-19: ' 'Youtube', 'journal-title': 'Polic�a asegura que f�rmaco lo sac� de cuadro cr�tico de COVID-19. ' 'Panamericana Televisi�n. 2020/05/18'}, { 'key': 'ref49', 'article-title': 'Updated 2020/05/17. Accessed 12/29/2020. 55. Santa Cruz I. Testimonio ' 'del Sub Oficial Darvin Condezo', 'journal-title': 'Polic�a fil�ntropo con Covid19 cuenta su testimonio y recuperaci�n ' 'gracias a f�rmaco. Herson Alc�ntara'}, { 'key': 'ref50', 'author': 'M Leon', 'journal-title': 'No mata al COVID-19, pero lo detiene'}, { 'key': 'ref51', 'author': 'Exitosa Noticias -Noticias Del Peru Y El Mundo', 'journal-title': 'COVID-19: Dr. Mass� indic� en qu� momento es m�s efectiva consumir ' 'ivermectina'}, { 'key': 'ref52', 'journal-title': 'Ivermectina: crece la demanda de f�rmaco antiparasitario para casos de ' 'covid-19. Realidad.pe | Noticias relevantes del Per� | Francisco ' 'Sagasti, Elecciones 2021, COVID-19, Reactiva Per�, Arranca Per�, ' 'Cuarentena focalizada'}, { 'key': 'ref53', 'journal-title': 'Piura: Detienen a dos personas con m�s de 200 dosis de ivermectina de ' 'contrabando; coronavirus; COVID-19; nnpp; PERU. El Comercio Per�. ' '2020/06/19'}, { 'key': 'ref54', 'doi-asserted-by': 'publisher', 'journal-title': 'Porres: incautan 20,000 frascos de ivermectina y detienen a 12 ' 'personas. Andina. Agencia Peruana de Noticias. 2020/05/27', 'DOI': '10.24265/campus.2016.v20n20.08'}, {'key': 'ref55', 'journal-title': 'Peru bet on cheap COVID antibody tests'}, { 'key': 'ref56', 'article-title': 'Covid-19: segundo informe para actualizar cifra de fallecidos se ' 'conocer� esta semana. Andina. Agencia Peruana de Noticias', 'author': 'Minsa', 'journal-title': 'Peru: PM announces new COVID-19 prevalence study. Andina. Agencia ' 'Peruana de Noticias. 2020/09/26'}, { 'key': 'ref57', 'author': 'T Welsh', 'year': '2020', 'journal-title': 'Inequality and corruption: Why Peru is losing its COVID-19 battle. ' 'Devex'}, { 'key': 'ref58', 'doi-asserted-by': 'publisher', 'first-page': '1247', 'DOI': '10.1016/s1473-3099(20)30553-3', 'volume': '20', 'author': 'H S Badr', 'year': '2020', 'journal-title': 'Association between mobility patterns and COVID-19 transmission in the ' 'USA: a mathematical modelling study. The Lancet Infectious Diseases'}, { 'key': 'ref59', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.10.05.20206888', 'article-title': 'The relative effects of non-pharmaceutical interventions on early ' 'Covid-19 mortality: natural experiment in 130 countries', 'author': 'J Stokes', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': 'ref60', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.10.29.20222414', 'article-title': 'How well does societal mobility restriction help control the COVID-19 ' 'pandemic? Evidence from real-time evaluation', 'author': 'J Oh', 'year': '2020', 'journal-title': 'medRxiv'}, { 'issue': '1', 'key': 'ref61', 'article-title': 'State-level tracking of COVID-19 in the United States', 'volume': '11', 'author': 'Hjt Unwin', 'year': '2020', 'journal-title': 'Nature Communications'}, { 'key': 'ref62', 'volume': '74', 'year': '2020', 'journal-title': 'Worldometer Coronavirus statistics'}, { 'key': 'ref63', 'doi-asserted-by': 'publisher', 'author': 'Worldometer Coronavirus Statistics', 'year': '2020', 'journal-title': 'Accessed', 'DOI': '10.47395/sjvd.13.2021.2.1.04'}, { 'key': 'ref64', 'volume': '2020', 'journal-title': 'Secretar�a de Gobierno Digital Presidencia del Consejo de Ministros'}, { 'key': 'ref65', 'volume': '2020', 'journal-title': 'National Death Information System (SINADEF). ' 'cloud.minsa.gob.pe/s/NctBnHXDnocgWAg/download'}, { 'key': 'ref66', 'doi-asserted-by': 'publisher', 'journal-title': 'Datos Abiertos de COVID', 'DOI': '10.1787/888933415882'}, { 'key': 'ref67', 'volume': '2020', 'journal-title': 'Secretar�a de Gobierno Digital Presidencia del Consejo de Ministros'}, { 'key': 'ref68', 'doi-asserted-by': 'publisher', 'journal-title': 'JHS COVID-19 Map. Johns Hopkins Coronavirus Resource Center', 'DOI': '10.1787/04440101-en'}, { 'key': 'ref69', 'article-title': 'Moquegua: llegan otros 45 m�dicos desde Lima para reforzar lucha contra ' 'el coronavirus', 'author': 'Editora Epdsesa', 'journal-title': 'Covid-19: a m�s de 22,000 personas atendi� Operaci�n Tayta-Yo Me Apunto ' 'en Cajamarca. Andina, Agencia Peruana de Noticias. 2020/08/02'}, { 'key': 'ref70', 'journal-title': 'Equipo del Ministerio de Salud realiza Operaci�n Tayta y brinda ' 'asistencia t�cnica en Moquegua'}, { 'key': 'ref71', 'author': 'C Llantoy', 'journal-title': 'Mediante empadronamiento ejecutado por 60 brigadistas de la mph y ' '"amachay'}, { 'key': 'ref72', 'article-title': 'Puno: Desde ma�ana implementar�n la operaci�n Tayta liderado por el ' 'Ej�rcito peruano. Radio Onda Azul', 'journal-title': 'Operaci�n Tayta permite fortalecer la atenci�n primaria de casos de ' 'COVID-19'}, { 'key': 'ref73', 'journal-title': 'Operaci�n tayta lleg� a hu�nuco para fortalecer lucha contra COVID-19. ' 'Gobierno Regional de Hu�nuco'}, { 'issue': '1', 'key': 'ref74', 'article-title': 'A pilot study of hydroxychloroquine in treatment of patients with ' 'common coronavirus disease-19 (COVID-19)', 'volume': '49', 'author': 'J Chen', 'year': '2020', 'journal-title': 'J Zhejiang Univ (Med Sci)'}, { 'key': 'ref75', 'journal-title': 'Gobierno entrega a Huancavelica m�s de 17 000 unidades de EPP y ' 'medicamentos para luchar contra el Covid-19. Ministerio de la ' 'Producci�n'}, { 'key': 'ref76', 'journal-title': 'Inician plan mega tayta 2020 en ayacucho para diagnosticar, tratar, ' 'aislar y asistir con alimentos a los casos positivos'}, { 'key': 'ref77', 'journal-title': 'Covid-19: inici� operaci�n Tayta con aplicaci�n de 3,000 pruebas de ' 'descarte'}, { 'key': 'ref78', 'journal-title': 'Jun�n: gobierno regional elabora ivermectina para tratamiento temprano ' 'de covid-19. Andina, Agencia Peruana de Noticias'}, { 'key': 'ref79', 'journal-title': 'Hospital Unanue mantiene producci�n regular de ivermectina. Gobierno ' 'Regional de Tacna'}, { 'key': 'ref80', 'journal-title': 'M�s de 500 adultos mayores son atendidos por el Mimp durante Operaci�n ' 'Tayta en Pasco'}, {'key': 'ref81', 'journal-title': 'Provincial de Pasco'}, {'key': 'ref82', 'journal-title': 'Provincial de Pasco'}, {'key': 'ref83', 'author': 'Covid Google', 'journal-title': 'Community Mobility Reports'}, { 'key': 'ref84', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.09.14.296814', 'article-title': 'Phylogenomics reveals multiple introductions and early spread of ' 'SARS-CoV-2 into Peru', 'author': 'E Juscamayta-L�pez', 'year': '2020', 'journal-title': 'bioRxiv'}, { 'key': 'ref85', 'journal-title': 'Covid-19: seroprevalencia en la ciudad de Iquitos es de 75 por ciento. ' 'Andina. Agencia Peruana de Noticias'}, { 'key': 'ref86', 'article-title': 'Global Human Settlement, Urban centres database 2018 visualisation; ' 'Urban Centre Database UCDB R2019A. 2020/11', 'volume': '30', 'year': '2017', 'journal-title': 'Instituto Nacional de Estad�stica e Inform�tica (INEI), Censos ' 'Nacionales'}, { 'key': 'ref87', 'author': 'P Fonseca', 'year': '2020', 'journal-title': 'Exclusive: Study suggests dengue may provide some immunity against ' 'COVID-19. Reuters'}, { 'key': 'ref88', 'doi-asserted-by': 'publisher', 'author': 'Salud Ministerio De', 'DOI': '10.4067/s0716-10182013000300004'}, { 'issue': '1', 'key': 'ref89', 'doi-asserted-by': 'publisher', 'first-page': '146', 'DOI': '10.17843/rpmesp.2015.321.1587', 'article-title': 'Dengue en el Per�: a un cuarto de siglo de su reemergencia', 'volume': '32', 'author': 'C Cabezas', 'year': '2015', 'journal-title': 'Revista Peruana de Medicina Experimental y Salud Publica'}, { 'key': 'ref90', 'doi-asserted-by': 'publisher', 'author': 'C Luna', 'journal-title': 'Repartir�n 10 mil kits con Ivermectina para combatir Covid-19 en ' 'Tuxtla. El Sie7e de Chiapas. 2020/07/03', 'DOI': '10.1787/4752b583-es'}, { 'issue': '6522', 'key': 'ref91', 'doi-asserted-by': 'publisher', 'first-page': '1277', 'DOI': '10.1126/science.abf5084', 'article-title': 'COVID-19 vaccine trial ethics once we have efficacious vaccines', 'volume': '370', 'author': 'D Wendler', 'year': '2020', 'journal-title': 'Science'}, { 'key': 'ref92', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/nejmoa2034577', 'article-title': 'Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine', 'author': 'F P Polack', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': 'ref93', 'doi-asserted-by': 'publisher', 'first-page': '191', 'DOI': '10.1056/nejmoa2034577', 'article-title': 'Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine (study ' 'protocol)', 'author': 'F P Polack', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': 'ref94', 'year': '2020', 'journal-title': 'The authors are indebted for this analysis to Dr. Peter McCullough, who ' 'communicated these observations in an email of December 14'}, { 'issue': '10', 'key': 'ref95', 'doi-asserted-by': 'publisher', 'first-page': '1122', 'DOI': '10.1177/009127002401382731', 'article-title': 'Safety, tolerability, and pharmacokinetics of escalating high doses of ' 'ivermectin in healthy adult subjects', 'volume': '42', 'author': 'C A Guzzo', 'year': '2002', 'journal-title': 'J Clin Pharmacol'}, { 'key': 'ref96', 'doi-asserted-by': 'publisher', 'author': 'A Krolewiecki', 'year': '2020', 'journal-title': 'Antiviral effect of high-dose ivermectin in adults with COVID-19: a ' 'pilot randomised, controlled, open label, multicentre trial', 'DOI': '10.2139/ssrn.3714649'}, { 'key': 'ref97', 'doi-asserted-by': 'publisher', 'author': 'D Scheim', 'year': '2020', 'journal-title': 'Ivermectin for COVID-19 treatment: clinical response at quasi-threshold ' 'doses via hypothesized alleviation of CD147-mediated vascular occlusion', 'DOI': '10.2139/ssrn.3636557'}, { 'key': 'ref98', 'doi-asserted-by': 'publisher', 'first-page': '51', 'DOI': '10.1002/9781118156391.ebcp001003', 'article-title': 'Professional issues and evidence-based practice: The quality problem in ' 'behavioral health care', 'volume': '1', 'author': 'W T O&apos;donohue', 'year': '2005', 'journal-title': 'Child and adolescent disorders'}, { 'key': 'ref99', 'doi-asserted-by': 'publisher', 'author': 'B Marshall', 'journal-title': 'Helicobacter Connections', 'DOI': '10.1002/chin.200642258'}, {'key': 'ref100', 'author': 'Nobel Prize Lecture', 'year': '2005'}, { 'key': 'ref101', 'doi-asserted-by': 'publisher', 'first-page': '1437', 'DOI': '10.1016/s0140-6736(88)90929-4', 'article-title': 'Prospective double-blind trial of duodenal ulcer relapse after ' 'eradication of Campylobacter pylori', 'volume': '2', 'author': 'B J Marshall', 'year': '1988', 'journal-title': 'Lancet'}, { 'issue': '3', 'key': 'ref102', 'doi-asserted-by': 'publisher', 'first-page': '145', 'DOI': '10.5694/j.1326-5377.1990.tb136833.x', 'article-title': 'Cure of duodenal ulcer after eradication of Helicobacter pylori', 'volume': '153', 'author': 'L L George', 'year': '1990', 'journal-title': 'Med J Aust'}, { 'key': 'ref103', 'first-page': '242', 'author': 'A Corsig', 'year': '1995', 'journal-title': 'Glaxo Holdings PLC: Zantac. In: Thomas R, ed. New Product Success ' 'Stories'}, { 'issue': '13', 'key': 'ref104', 'doi-asserted-by': 'publisher', 'first-page': '1489', 'DOI': '10.1001/archinte.1997.00440340131013', 'article-title': 'Time trends of physician visits and treatment patterns of peptic ulcer ' 'disease in the United States', 'volume': '157', 'author': 'S Munnangi', 'year': '1997', 'journal-title': 'Arch Intern Med'}, { 'key': 'ref105', 'year': '2020', 'journal-title': 'Australian GPs urged to prescribe ivermectin triple therapy to fight ' 'COVID-19. Thepharmaletter'}, { 'issue': '5', 'key': 'ref106', 'doi-asserted-by': 'publisher', 'first-page': '343', 'DOI': '10.1111/myc.12599', 'article-title': 'A re-appraisal of the conventional history of antibiosis and Penicillin', 'volume': '60', 'author': 'S N Arseculeratne', 'year': '2017', 'journal-title': 'Mycoses'}, { 'key': 'ref107', 'doi-asserted-by': 'publisher', 'first-page': '163', 'DOI': '10.1016/s0065-2164(01)49013-7', 'article-title': 'Alexander Fleming and the discovery of penicillin', 'volume': '49', 'author': 'J W Bennett', 'year': '2001', 'journal-title': 'Advances in Applied Microbiology'}, { 'issue': '6239', 'key': 'ref108', 'doi-asserted-by': 'publisher', 'first-page': '387', 'DOI': '10.1016/s0140-6736(00)41962-8', 'article-title': 'General and local administration of penicillin', 'volume': '241', 'author': 'M E Florey', 'year': '1943', 'journal-title': 'The Lancet'}, { 'issue': '16', 'key': 'ref109', 'doi-asserted-by': 'publisher', 'first-page': '1007', 'DOI': '10.1001/jama.1943.02840510001001', 'article-title': 'Penicillin therapy of surgical infections in the US Army: A report', 'volume': '123', 'author': 'C Lyons', 'year': '1943', 'journal-title': 'Journal of the American Medical Association'}, { 'issue': '18', 'key': 'ref110', 'doi-asserted-by': 'publisher', 'first-page': '1217', 'DOI': '10.1001/jama.1943.02840350001001', 'article-title': 'Penicillin in the treatment of infections; 500 cases', 'volume': '122', 'author': 'C S Keefer', 'year': '1943', 'journal-title': 'Journal of the American Medical Association'}, { 'issue': '1', 'key': 'ref111', 'doi-asserted-by': 'publisher', 'first-page': '52', 'DOI': '10.1053/j.spid.2004.02.001', 'article-title': 'Penicillin: its discovery and early development', 'volume': '15', 'author': 'B L Ligon', 'year': '2004', 'journal-title': 'Seminars in Pediatric Infectious Diseases'}, { 'issue': '6', 'key': 'ref112', 'doi-asserted-by': 'publisher', 'first-page': '679', 'DOI': '10.1016/s0048-7333(99)00045-1', 'article-title': 'Antibiotics, invention and innovation', 'volume': '29', 'author': 'W Kingston', 'year': '2000', 'journal-title': 'Research Policy'}, { 'issue': '4918', 'key': 'ref113', 'doi-asserted-by': 'publisher', 'first-page': '441', 'DOI': '10.1038/201441a0', 'article-title': 'Production of Penicillin in the United States (1941-1946)', 'volume': '201', 'author': 'A N Richards', 'year': '1964', 'journal-title': 'Nature'}, { 'key': 'ref114', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2021.01.18.426984', 'article-title': 'Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 ' 'vaccine-elicited human sera', 'author': 'A Muik', 'year': '2021', 'journal-title': 'bioRxiv'}, { 'key': 'ref115', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2021.01.18.427166', 'article-title': 'SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 ' 'donor plasma', 'author': 'C K Wibmer', 'year': '2021', 'journal-title': 'bioRxiv'}, { 'key': 'ref116', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.12.31.425021', 'article-title': 'Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding ' 'domain that affect recognition by polyclonal human serum antibodies', 'author': 'A J Greaney', 'year': '2021', 'journal-title': 'bioRxiv'}, { 'key': 'ref117', 'author': 'K Wu', 'journal-title': 'mRNA-1273 vaccine induces neutralizing antibodies against spike mutants ' 'from global SARS-CoV-2 variants'}, { 'key': 'ref118', 'doi-asserted-by': 'crossref', 'DOI': '10.7554/eLife.61312', 'article-title': 'Escape from neutralizing antibodies by SARS-CoV-2 spike protein ' 'variants', 'volume': '9', 'author': 'Y Weisblum', 'year': '2020', 'journal-title': 'eLife'}, { 'issue': '1', 'key': 'ref119', 'doi-asserted-by': 'publisher', 'first-page': '44', 'DOI': '10.1016/j.chom.2020.11.007', 'article-title': 'Complete Mapping of Mutations to the SARS-CoV-2 Spike ReceptorBinding ' 'Domain that Escape Antibody Recognition', 'volume': '29', 'author': 'A J Greaney', 'year': '2021', 'journal-title': 'Cell Host & Microbe'}], 'container-title': 'SSRN Electronic Journal', 'original-title': [], 'language': 'en', 'deposited': { 'date-parts': [[2021, 2, 5]], 'date-time': '2021-02-05T10:47:27Z', 'timestamp': 1612522047000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.ssrn.com/abstract=3765018'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021]]}, 'references-count': 119, 'URL': 'http://dx.doi.org/10.2139/ssrn.3765018', 'relation': {}, 'ISSN': ['1556-5068'], 'subject': [], 'published-other': {'date-parts': [[2021]]}, 'container-title-short': 'SSRN Journal', 'published': {'date-parts': [[2021]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit